Cullen Frost, Global Assets Lift IBM Stakes 3.8% and 33.5% as First Citizens Cuts
Cullen Frost Bankers Inc boosted its stake in IBM by 3.8%, adding 3,227 shares to reach 88,856 shares valued at $25.07 million, while Global Assets Advisory LLC increased its position by 33.5% to 12,044 shares worth $3.40 million in the third quarter. First Citizens Bank & Trust trimmed its IBM holdings by 9.4%, selling 2,693 shares to end the period with 26,064 shares valued at $7.35 million.
1. Operating Margin and Q3 Results
In its October 22 earnings release, IBM reported third-quarter revenue of $16.33 billion, a 9.1% increase year-over-year, driven by growth in cloud and software services. The company posted non-GAAP earnings per share of $2.65, surpassing analyst consensus by $0.20. Importantly, IBM’s operating margin expanded by 120 basis points to 19.8%, reflecting disciplined cost management and higher-margin software sales. Return on equity reached 37.8%, underscoring efficient capital deployment across its strategic businesses.
2. Institutional Stake Changes
During the third quarter, several institutional investors adjusted their IBM positions. Cullen Frost Bankers increased its stake by 3.8%, adding 3,227 shares to reach 88,856 shares valued at $25.07 million. Global Assets Advisory boosted its holding by 33.5%, acquiring 3,024 shares for a total of 12,044 shares valued at $3.40 million. Conversely, First Citizens Bank & Trust trimmed its position by 9.4%, selling 2,693 shares and ending the period with 26,064 shares worth $7.35 million. Institutional ownership remains at 58.96%.
3. Analyst Ratings and Price Targets
Following the earnings beat, a number of Wall Street analysts updated their views on IBM. Jefferies upgraded the stock from Hold to Buy and raised its target from $300 to $360, citing accelerating software margins. RBC increased its target from $300 to $350 and maintained an Outperform rating. BMO Capital Markets reiterated Market Perform but lifted its target to $305. One analyst maintains a Sell rating; five rate it Hold; twelve rate it Buy; and one rates it Strong Buy, yielding a consensus Moderate Buy recommendation and an average target around $307.
4. Balance Sheet and Valuation Metrics
IBM’s balance sheet continues to support strategic investments, with a debt-to-equity ratio of 1.97 and liquidity ratios near parity (current ratio 0.93, quick ratio 0.89). The stock trades at a forward price-to-earnings ratio of approximately 2.83 for growth-adjusted earnings, reflecting investor confidence in mid-single-digit revenue growth and margin expansion. With a beta of 0.70, IBM offers relative stability alongside a dividend yield near 5%, appealing to income-oriented portfolios.